Skip to content

Drug interactions

Deflazacort + Fondaparinux

Severity: Minor

Deflazacort and Fondaparinux: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Systemic corticosteroids can raise GI bleeding risk through mucosal injury and may impair vascular integrity. The INR-related warning applies to warfarin, not fondaparinux, so the effect here is bleeding risk rather than altered anticoagulant potency.

What this interaction means in plain words

Deflazacort and Fondaparinux have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Deflazacort belongs to Miscellaneous; Fondaparinux belongs to Cardiovascular.

Evidence level: Low

Why it happens

Corticosteroid-related mucosal injury and vascular fragility add to the bleeding risk of anticoagulation; no pharmacokinetic interaction.

What to do

Watch for signs of GI bleeding, especially with prolonged or high-dose steroid use. Add gastroprotection if other risk factors are present.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Deflazacort and Fondaparinux, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Deflazacort with Fondaparinux?

MediHelp rates the interaction as minor. Deflazacort and Fondaparinux have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Systemic corticosteroids can raise GI bleeding risk through mucosal injury and may impair vascular integrity. The INR-related warning applies to warfarin, not fondaparinux, so the effect here is bleeding risk rather than altered anticoagulant potency.

How serious is the interaction between Deflazacort and Fondaparinux?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Watch for signs of GI bleeding, especially with prolonged or high-dose steroid use. Add gastroprotection if other risk factors are present.

What other medicines interact with Fondaparinux?

MediHelp also lists interactions of Fondaparinux with, for example, Defibrotide, Ketorolac, Abciximab. The full list is on the Fondaparinux page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in